Background and objective: Acute kidney injury (AKI)
is an important contributing factor to the mortality of
critically ill neonates. However, the standardized AKI
for this population is still inconclusive until neonatal
RIFLE score has been proposed in 2013. This study
aimed to identify the incidence of AKI in critically ill
neonates by using neonatal RIFLE.
Methods: In this descriptive, retrospective study
included all neonates admitted to the tertiary care
NICU during January 2013-December 2014. The patient
demographics, co-morbidities, and outcomes data
were recorded. AKI was classified by neonatal RIFLE
into urine output-based criteria and serum
creatinine-based criteria. The objectives were 1. To
determine the incidence of AKI as defined by
neonatal RIFLE score in NICU. 2. To identify factors
affecting AKI in critically ill neonates.
Results: A total of 263 neonates were enrolled. The
incidence of AKI by neonatal RIFLE was 24.3%,
compared with 8% of those diagnosed by attending
physicians (p<0.001). Forty-eight of 64 patients (75%)
with AKI were classified by urine output criteria only,
eight patients (12.5%) were diagnosed by eGFR
criteria only and eight patients (12.5%) matched both
criteria. Congenital heart diseases and administration
of vancomyci n were found to be si gni ficant
independent factors of AKI in the NICU (p<0.05). Most
neonates with AKI (81.3%) had complete renal
recovery. The mortality rate of neonates with AKI by
neonatal RIFLE was 26.5% compared to 4% of neonates without AKI.
Conclusion: The incidence of neonatal AKI by using
urine output criteria from neonatal RIFLE was high
(24%) and useful to detect and early management of
neonatal AKI.